Frank Albers

About Frank Albers

I am an MD with a PhD in transplantation immunology and over 20 years experience in the pharmaceutical industry with a patient focused mindset in roles of increasing responsibility in the areas of Respiratory, Allergy and Immuno-inflammation Clinical Development and Medical Affairs from a global, strategic and an operational, country perspective. I offer comprehensive medical expertise and background in planning and implementing globally aligned phase II-IV clinical development and life cycle management strategies and plans, including clinical trial and real-world study designs, analyzing and interpreting clinical trial results, drug safety assessments (DSURs), developing and executing a comprehensive publication strategy as well as supporting pre- and post-approval marketing plans. Hands-on involvement with 3 NDA/BLA preparations and submission reviews with active and supportive participation in 3 FDA Pulmonary-Allergy Drugs Advisory Committees (PADAC).

Experience

1. Senior Global Medical Lead

   Avillion Life Sciences

   Jun 2019 — Present

   Medical Lead accountable for overseeing the Clinical and Medical aspects of the PT027 (budesonide/albuterol MDI) clinical development program of 3 Phase 3 studies including Medical Monitoring and Pharmacovigilance, Study Governance and Steering Committee and medical support of study conduct and reporting as well as FDA filing leading to successful approval of Airsupra® in January 2023.

Education

• Gymnasium Kiel-Wellingdort

  Abitur, Biology, Maths

  1979 — 1989

• Kiel University

  Doctorate (PhD), Transplantation Immunology

  1996 — 2002

• Kiel University

  MD, Human Medicine

  1991 — 1999

Skills

• Data Analysis
• Clinical Study Design
• Clinical Trials
• Great People Skills
• Respiratory
• Clinical Development
• Health Economics
• CRO
• Regulatory Affairs
• Copd
• Clinical Research
• Advisory Boards
• Pharmaceuticals
• Biologics
• Data Interpretation
• Cross-Functional Team Leadership
• Outcomes Research
• Immunology
• Allergy
• Drug Development
• Medical Research
• Medical
• Ms Office Suite
• Data Presentation
• Team Leadership
• Dry Powder Inhalers
• Strategic Leadership
• Microsoft Office
• Pharmacovigilance
• Project Management
• Medical Writing
• U.s. Food and Drug Administration (Fda)
• Medicine
• Medical Affairs
• Regulatory Submissions
• Team Management
• Pharmaceutical Industry
• Fda
• Drug Safety
• Respiration